1 unknown. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Personal Protective Equipment: new trials by email Literature Review of Personal Protective Equipment trials Research Report on Personal Protective Equipment
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Daily Regimen of Tenofovir/Emtricitabine as Prevention for COVID-19 in Health Care Personnel in Colombia Tenofovir/ Emtricitabine ( 300 mg / 200 mg daily during 60 days) + Personal Protective Equipment (PPE), Placebo (1 tablet daily during 60 days) + Personal Protective Equipment (PPE) - Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19 | Phase 2 / Phase 3 | Unknown | Hospital Universitario San Ignacio | 950 | 2020-08-30 | 2020-08-19 |
COVID-19 (1)